Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Docetaxel With or Without AZD6244 in Melanoma [Phase 2]
Phase 2 trial evaluating docetaxel with or without the MEK inhibitor AZD6244 in melanoma has completed, and the results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: BESPOKE Study of ctDNA Guided Immunotherapy
The BESPOKE trial evaluating ctDNA-guided immunotherapy has completed, according to ClinicalTrials.gov.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Phase 1 Study Using TRIMELVax for Stage IIIC / IV Melanoma Patients [Phase 1]
This document reports a Phase 1 clinical trial update for TRIMELVax in patients with stage IIIC/IV melanoma, conducted by the University of …
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer [EARLY_Phase 1]
Early-phase trial evaluating pharmacogenomics-guided use of supportive care medications in patients with advanced cancers; the study has com…
-
CLINICAL_TRIALS trial_result · 2024-08-12Clinical Trial Update: Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma [Phase 2]
A Phase 2 trial evaluating denosumab in combination with a PD-1 inhibitor in stage III/IV melanoma has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011) [Phase 2]
Phase 2 trial evaluating Gebasaxturev (V937) administered intravenously or intratumorally with pembrolizumab versus pembrolizumab alone in m…
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: Longitudinal Study of Behavioral Changes, Economic and Sociological After CAncer [NA]
A completed longitudinal clinical trial update examining behavioral, economic, and sociological outcomes after cancer, covering breast cance…
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: MCS110 With BRAF/MEK Inhibition in Patients With Melanoma [Phase 1, Phase 2]
Dana-Farber Cancer Institute reported results from a Phase 1/2 trial evaluating MCS110 in combination with BRAF/MEK inhibitors for melanoma.…
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting
A completed clinical trial evaluated circulating tumor DNA (ctDNA) analysis as a tool for earlier detection of melanoma recurrence in high-r…
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers [Phase 1]
Phase 1 clinical trial evaluating nab-paclitaxel in combination with bevacizumab in patients with unresectable stage IV melanoma or gynecolo…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: Pre-Treatment of Highly Suspicious Pigmented Skin Lesions With Interleukin-2 [Phase 3]
Phase 3 trial evaluating pre-treatment with Interleukin-2 for highly suspicious pigmented skin lesions (melanoma and melanoma in situ) was t…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: A Study to Assess Safety of Relatlimab With Ipilimumab in Participants With Advanced Melanoma Who Progressed on Anti-Programmed Cell Death Protein 1 (Anti-PD-1) Treatment [Phase 1]
The Phase 1 study evaluating the safety of relatlimab in combination with ipilimumab in advanced melanoma patients who progressed on anti-PD…
-
CLINICAL_TRIALS trial_result · 2024-07-19Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors [Phase 1, Phase 2]
Phase 1/2 study of HH2710 in patients with melanoma and other advanced tumors was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-07-17Clinical Trial Update: LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study of the investigational agent LY3022855 in combination with BRAF/MEK i…
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer [Phase 1]
Phase 1 trial evaluating the addition of pembrolizumab to standard antiretroviral therapy in HIV-positive patients with cancer. The study ha…
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating an investigational melanoma vaccine that uses CD40 activation and TLR agonists to target neoantigens and…
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating Imprime PGG in combination with pembrolizumab in advanced melanoma and triple-negative breast cancer has completed,…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) [Phase 1]
This update reports the completion of a Phase 1 study (DUET-3) evaluating XmAb23104 in patients with selected advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid [Phase 1]
Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of Stimotimagene Copolymerplasmid in multiple cancer types; the study ha…
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping [Phase 2]
Phase 2 study evaluating Lymphoseek for lymph node mapping in pediatric patients with melanoma or rhabdomyosarcoma (and other solid tumors);…
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases [Phase 2]
Phase 2 clinical trial update evaluating the combination of radiosurgery and nivolumab for brain metastases in various cancers, with complet…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of PF-06952229 in adults with advanced solid tumors was terminated. Results were posted on 2024-06-26.
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: Phase 1 Safety Study of Encorafenib in Chinese Patients With Advanced Metastatic BRAF V600E Mutant Solid Tumors [Phase 1]
Phase 1 safety study evaluating encorafenib in Chinese patients with advanced/metastatic BRAF V600E-mutant solid tumors, including melanoma …
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors
A completed clinical trial comparing three in vivo microscopic imaging techniques for diagnosing pigmented skin tumors conducted by Centre H…
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: RATIO: Rational Approach To Immuno-Oncology [NA]
A clinical trial update for the RATIO study on immuno-oncology in metastatic melanoma indicates the trial status is completed.